Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 327,247 |
|
|||||
| News | - | ||||||
| Day High | 1.32 | Low High |
|||||
| Day Low | 1.20 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Beyond Air Inc | XAIR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.14 | 11.48% | 1.36 | 18:54:17 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.20 | 1.20 | 1.32 | 1.30 | 1.22 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,331 | 327,247 | US$ 1.28 | US$ 417,610 | - | 1.06 - 6.36 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:54:17 | formt | 400 | US$ 1.36 | USD |
Beyond Air Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 46.85M | 36.04M | - | 0 | -55.82M | -1.55 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Beyond Air News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XAIR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.21 | 1.32 | 1.06 | 1.13 | 469,118 | 0.15 | 12.40% |
| 1 Month | 1.61 | 1.69 | 1.06 | 1.24 | 332,758 | -0.25 | -15.53% |
| 3 Months | 1.76 | 2.17 | 1.06 | 1.58 | 291,426 | -0.40 | -22.73% |
| 6 Months | 2.51 | 2.61 | 1.06 | 1.69 | 399,474 | -1.15 | -45.82% |
| 1 Year | 5.81 | 6.36 | 1.06 | 2.86 | 415,571 | -4.45 | -76.59% |
| 3 Years | 6.18 | 16.41 | 1.06 | 6.30 | 396,617 | -4.82 | -77.99% |
| 5 Years | 5.65 | 16.41 | 1.06 | 6.37 | 344,591 | -4.29 | -75.93% |
Beyond Air Description
| Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company which develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections. |
